T1	Participants 119 147	systemic lupus erythematosus
T2	Participants 415 491	two tertiary care centres of patients with SLE according to the ACR criteria
T3	Participants 493 529	with incident (no more than 15 days)
T4	Participants 530 563	onset of severe NP manifestations
T5	Participants 564 655	such as seizures, optic neuritis, peripheral or cranial neuropathy, coma, brainstem disease
T6	Participants 660 679	transverse myelitis
T7	Participants 1124 1135	32 patients
